Cost-Effectiveness, Efficacy, and Safety Analysis of Tailored Therapy in Patients with <i>Helicobacter pylori</i> Infection
Recently in Korea, where triple therapy is accepted as the first-line <i>Helicobacter pylori</i> (<i>H. pylori</i>) eradication treatment, antibiotic resistance to clarithromycin has increased considerably, resulting in eradication rates of less than 80%. We investigated the...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/12/2619 |